2,6-dichloroindophenol has been researched along with Cancer of Colon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornelisse, CJ; Schor, NA | 1 |
| Weingast-Johnson, J; Winterbourne, DJ | 1 |
| Akman, SA; Forrest, GL; Hipsher, C; Johnson, R; Pan, SS | 1 |
3 other study(ies) available for 2,6-dichloroindophenol and Cancer of Colon
| Article | Year |
|---|---|
Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas.
Topics: 2,6-Dichloroindophenol; Aged; Colonic Neoplasms; Cytochrome c Group; Cytochrome Reductases; Female; Humans; Intestinal Mucosa; Male; Middle Aged; NAD; NADH Dehydrogenase; NADH, NADPH Oxidoreductases; NADP; NADPH Dehydrogenase | 1983 |
Purines induce lipofuscin formation in a colon carcinoma cell line.
Topics: 2,6-Dichloroindophenol; Colonic Neoplasms; Free Radicals; Guanine; Humans; Kinetics; Lipofuscin; Methylene Blue; Microscopy, Fluorescence; Oxypurinol; Purines; Staining and Labeling; Tumor Cells, Cultured; Xanthine; Xanthine Dehydrogenase; Xanthines | 1994 |
The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
Topics: 2,6-Dichloroindophenol; Carbon Radioisotopes; Cell Extracts; Cell Size; Cell Survival; Colonic Neoplasms; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Intracellular Fluid; Microsomes; Mitomycin; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Porfiromycin; RNA, Messenger; Tissue Distribution; Transcription, Genetic; Tumor Cells, Cultured; Vitamin K | 1992 |